03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Oncodox-O 50mg : | |
Type | Medicine Non Marketed |
Originator | Adriblastina 50mg* |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Cipla |
Responsible Party | Cipla Ltd |
Origin | India |
Manufacturer | Cipla Ltd |
Manufacturing Type | G |
Origin | India |
ATC | L01DB01 |
Oncodox-O 50mg :
Oncodox-O 50mg :
Oncodox-O 50mg :
Oncodox-O 50mg :
Oncodox-O 50mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Abnormal ECG | Very Common |
Acute lymphocytic leukaemia (Acute lymphoblastic leukemia) | Not known |
Acute myeloid leukaemia | Not known |
Administration site reaction | Common |
Alopecia | Very Common |
Amenorrhoea (amenorrhea) | Not known |
Anaemia | Very Common |
Anaphylactic reactions | Not known |
Anorexia | Very Common |
Asthenia | Very Common |
Atrioventricular block (AVB) | Not known |
Azoospermia | Not known |
Bundle branch block | Not known |
Chills | Very Common |
Colitis | Not known |
Congestive heart failure | Common |
Conjunctivitis | Common |
Dehydration | Not known |
Diarrhoea (Diarrhea) | Very Common |
Ejection fraction decreased | Very Common |
Eruption | Common |
Fever | Very Common |
Gastric erosions | Not known |
Gastroduodenal haemorrhage | Not known |
Haemorrhage | Not known |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Very Common |
Hot flush | Not known |
Hyperuricaemia | Not known |
Infection | Very Common |
Keratitis | Not known |
Lacrimation increased (Epiphora) | Not known |
Leucopenia (Leukopenia) | Very Common |
Malaise | Not known |
Mucositis | Very Common |
Nausea | Very Common |
Neutropenia | Very Common |
Oesophagitis | Common |
Oligospermia | Not known |
Phlebitis | Not known |
Photosensitivity reaction | Not known |
Pruritus | Not known |
Radiation recall reaction (dermatologic) | Not known |
Septicemia | Common |
Shock | Not known |
Sinus tachycardia | Common |
Skin hyperpigmentation | Common |
Stomatitis | Very Common |
Tachyarrhythmia | Not known |
Thrombocytopenia (Thrombopenia) | Very Common |
Thromboembolism | Uncommon |
Thrombophlebitis | Not known |
Transaminases abnormal | Very Common |
Urine coloring red | Not known |
Urticaria | Common |
Vomiting | Very Common |
Weight increased (weight gain) | Very Common |
NB : Products With Same Indication |
Different Units By MoH Code
Oncodox-O 50mg MoH 7053 :
Form | Powder for solution for injection |
Packaging | Vial + Ampoule |
Package Size | Box of 1 |
Strength | 50mg |
Storage Condition | <25°C Away from moisture |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 219573/09 |
Submission date | 01/01/2009 |
Registration Year | 2013 |
Archived Date | 03/05/2023 |
Price Comparison
You have to register to view this info
Drop File